Rivermark Medical, Inc.
ID: 8109884Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
2
Funding Rounds
$31.8m
Money raised
Recent Funding Rounds
Overview
Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function.
- Website:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Rivermark Medical, Inc. has raised a total of $31.75m in funding over 2 rounds.
Key Insights:
- Rivermark Medical October 2024 Series C Funding Round: $30m
- Rivermark Medical, Inc. Funding Round, November 2021: $1.75m
Industries
Rivermark Medical, Inc. is active in the following industries: